Skip to main content

Table 4 Comparison of per-segment native T1 times and ECV in patients before/after electric cardioversion

From: Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation

   

Patient 1

Patient 2

Patient 3

    

P value

 

P value

 

P value

Diastole

A: fixed

Native T1 (ms)

1294.67 ± 16.50

A vs. B: <0.01

1233.83 ± 25.09

A vs. B: <0.05

1268.80 ± 34.85

A vs. B: <0.01

B: 1st HRD

Native T1 (ms)

1353.30 ± 36.55

B vs. C: >0.05

1241.17 ± 16.08

B vs. C: >0.05

1289.57 ± 13.29

B vs. C: >0.05

C: 2nd HRD

Native T1 (ms)

1342.60 ± 18.12

A vs. C: <0.01

1245.07 ± 11.98

A vs. C: <0.05

1289.07 ± 16.05

A vs. C: <0.01

A: fixed

ECV (%)

23.12 ± 0.22

A vs. B: <0.01

22.28 ± 1.00

A vs. B: <0.01

27.25 ± 0.34

A vs. B: <0.01

B: 1st HRD

ECV (%)

25.51 ± 0.88

B vs. C: >0.05

24.96 ± 0.24

B vs. C: >0.05

28.49 ± 0.37

B vs. C: >0.05

C: 2nd HRD

ECV (%)

25.47 ± 1.14

A vs. C: <0.01

25.60 ± 0.97

A vs. C: <0.01

28.50 ± 0.21

A vs. C: <0.01

Systole

A: fixed

Native T1 (ms)

1283.30 ± 34.76

A vs. B: <0.01

1209.90 ± 33.24

A vs. B: <0.01

1249.73 ± 39.49

A vs. B: <0.01

B: 1st HRD

Native T1 (ms)

1345.1 ± 23.40

B vs. C: >0.05

1246.37 ± 33.92

B vs. C: >0.05

1274.70 ± 17.68

B vs. C: >0.05

C: 2nd HRD

Native T1 (ms)

1339.57 ± 25.75

A vs. C: <0.01

1250.80 ± 36.09

A vs. C: <0.01

1256.10 ± 17.91

A vs. C: <0.05

A: fixed

ECV (%)

23.57 ± 0.62

A vs. B: <0.05

22.86 ± 2.58

A vs. B: <0.05

27.01 ± 1.50

A vs. B: <0.05

B: 1st HRD

ECV (%)

24.41 ± 1.74

B vs. C: >0.05

23.74 ± 0.56

B vs. C: >0.05

27.13 ± 0.65

B vs. C: >0.05

C: 2nd HRD

ECV (%)

24.76 ± 0.52

A vs. C: <0.05

23.56 ± 1.21

A vs. C: <0.05

27.14 ± 0.90

A vs. C: <0.05

  1. Data are presented in mean ± standard deviation. ECV extracellular volume, HRD heart-rate-dependent